Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Protocol With BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy: A Prospective Open Label Single-Center Study

NCT05363644 is registered in ClinicalTrials.gov with AdventHealth as lead sponsor.

NCT NCT05363644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05363644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Protocol With BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy: A Prospective Open Label Single-Center Study
Lead sponsor
AdventHealth
Phase
Phase 3
Overall status
Withdrawn
Start date
April 1, 2023
Completion date
June 30, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction following radical prostatectomy, incontinence, urinary, prostate cancer, prostatectomy